Evaluation of heparin assay for coagulation management in newborns undergoing ECMO

American Journal of Clinical Pathology

Volumn 134, Issue 6, 2010, Pages 950-954

  Khaja, Wassia A ^a   Bilen, Ozlem ^a   Lukner, Ralf B ^a   Edwards, Rachel ^a   Teruya, Jun ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Anticoagulation; ECMO; Extracorporeal membrane oxygenation; Heparin assay; Neonatal coagulation

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; HEPARIN; HEPARIN LYASE;

ACTIVATED CLOTTING TIME; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; CLINICAL ARTICLE; EXTRACORPOREAL OXYGENATION; FEMALE; HEPARIN ASSAY; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL RECORD REVIEW; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN MONITORING; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY;

ANTICOAGULANTS; EXTRACORPOREAL MEMBRANE OXYGENATION; FACTOR XA; FEMALE; HEPARIN; HERNIA, DIAPHRAGMATIC; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; MALE; MECONIUM ASPIRATION SYNDROME; PARTIAL THROMBOPLASTIN TIME; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEPSIS; WHOLE BLOOD COAGULATION TIME;

EID: 78649684706     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPGVD62LKKVDLH     Document Type: Article

References (8)

1. Tan LH, Du LZ, He XJ, et al. Two successful neonatal extracorporeal membrane oxygenation treatment for severe heart failure after cardiac surgery. Chin Med J (Engl). 2009;122:2672-2674.
2. Betit P, Craig N. Extracorporeal membrane oxygenation for neonatal respiratory failure. Respir Care. 2009;54:1244-1251.
3. Rajagopal SK, Almond CS, Laussen PC, et al. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry. Crit Care Med. 2010;38:382-387.
4. Hirthler MA, Blackwell E, Abbe D, et al. Coagulation parameter instability as an early predictor of intracranial hemorrhage during extracorporeal membrane oxygenation. J Pediatr Surg. 1992;27:40-43.
5. Hattersley PG, Hayse D. The effect of increased contact activation time on the activated partial thromboplastin time. Am J Clin Pathol. 1976;66:479-482.
6. Searles B, Nasrallah F, Darling E, et al. How does the age of a blood sample affect it's activated clotting time? comparison of eight different devices. J Extra Corpor Technol. 2002;34:175-177.
7. Uden DL, Payne NR, Kriesmer P, et al. Procedural variables which affect activated clotting time test results during extracorporeal membrane oxygenation therapy. Crit Care Med. 1989;17:1048-1051.
8. Baird CW, Zurakowski D, Robinson B, et al. Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival. Ann Thorac Surg. 2007;83:912-920.